Koyfin Home > Directory > Health Care > Adamas Pharma > Gross Profit

Adamas Pharma Gross Profit Chart (ADMS)

Adamas Pharma annual/quarterly Gross Profit from 2012 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Adamas Pharma Gross Profit for the quarter ending June 06, 2020 was $18m a 29.38% increase of 5m year over year
  • Adamas Pharma Gross Profit for the last 12 months ending June 06, 2020 was $61m a 19.74% increase of 12m year over year
  • Adamas Pharma Annual Gross Profit for 2019 was $52m a 35.95% increase of 19m from 2018
  • Adamas Pharma Annual Gross Profit for 2018 was $33m a 98.34% increase of 33m from 2017
  • Adamas Pharma Annual Gross Profit for 2017 was $1m a -3.25% decrease of 0m from 2016
Other Income Statement Metrics:
  • Adamas Pharma EBITDA for the quarter ending December 12, 2018 was $-25m a -22.88% increase of 6m year over year
  • Adamas Pharma Net Income for the quarter ending December 12, 2018 was $-29m a -21.08% increase of 6m year over year
  • Adamas Pharma Total Revenue for the quarter ending September 09, 2018 was $11m a 94.65% increase of 10m year over year
View Chart On Koyfin

Quarterly ADMS Gross Profit Data

06/2020$18m
03/2020$14m
12/2019$16m
09/2019$13m
06/2019$12m
03/2019$11m
12/2018$13m
09/2018$11m
06/2018$7m
03/2018$3m

Annual ADMS Gross Profit Data

2019$52m
2018$33m
2017$1m
2016$1m
2015$2m
2014$56m
2013$71m
2012$37m
2011$2m